FIELD: biotechnology.
SUBSTANCE: invention relates to treatment and a pharmaceutical composition used in treating a neurological disease or condition in a subject, to preventing loss of neurons in the central nervous system (CNS) of a subject, to stimulate growth and recovery of neurons in the CNS of a subject and to increase expression of at least one of the following in the CNS subject: dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32), dopamine receptor D2 and neurotrophic cerebral factor (BDNF). Methods include systemic administration to a subject of a pharmaceutical composition containing immature stem cells of human tooth pulp (hIDPSC), wherein hIDPSC express a cerebral neurotrophic factor (BDNF), dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32), CD44 and CD13.
EFFECT: invention widens the range of equipment.
37 cl, 7 tbl, 51 dwg, 16 ex
Title | Year | Author | Number |
---|---|---|---|
STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS, COMPOSITIONS THEREOF AND METHODS OF PRODUCING SAID MESENCHYMAL AND NEURONAL MARKERS | 2017 |
|
RU2741839C2 |
PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR USE IN THERAPY | 2015 |
|
RU2714236C2 |
METHOD OF PRODUCING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH HUNTINGTON'S DISEASE | 2011 |
|
RU2458983C1 |
TREATMENT OF DIABETES WITH HELP OF PANCREATIC ENDOCRINE PROGENITOR CELLS | 2011 |
|
RU2682719C2 |
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONS AND GLIAL CELLS OBTAINED BY DIRECTED DIFFERENTIATION OF INDUCED HUMAN PLURIPOTENT STEM CELLS | 2018 |
|
RU2690846C1 |
PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
TRANSPLANTATION OF NERVE CELLS FOR TREATMENT OF NEURODEGENERATIVE STATES | 2005 |
|
RU2434636C2 |
IMPROVING ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2665364C2 |
SC-β CELLS AND COMPOSITIONS AND METHODS FOR THEIR CREATION | 2014 |
|
RU2813705C1 |
Authors
Dates
2021-02-11—Published
2017-03-09—Filed